KOA SHOJI HOLDINGS CO.,LTD.
9273 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 横浜市港北区日吉七丁目１３−１５
- Website:
- https://www.koashoji-hd.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
KOA SHOJI HOLDINGS CO., LTD. is a prominent leader in the pharmaceutical sector, committed to supporting the evolving needs of a "super-aging society." The company focuses on enhancing corporate value while addressing critical social issues related to health and well-being. With a long-term business plan aimed at 2030, KOA SHOJI strives to contribute to the sustainable development of society. The organization emphasizes a robust sustainability framework and actively engages in initiatives that improve people's lives. By leveraging its expertise in pharmaceuticals, KOA SHOJI HOLDINGS aims to create innovative solutions that reflect its dedication to health and societal advancement.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-20 03:20 |
Inside Information Statement
臨時報告書
|
Japanese | 18.4 KB | |
| 2025-02-13 05:00 |
Interim Report
半期報告書－第11期(2024/07/01－2025/06/30)
|
Japanese | 191.9 KB | |
| 2025-02-13 05:00 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-09-30 08:27 |
Inside Information Statement
臨時報告書
|
Japanese | 24.6 KB | |
| 2024-09-30 08:26 |
Internal Control over Financial Reporting
内部統制報告書－第10期(2023/07/01－2024/06/30)
|
Japanese | 23.4 KB | |
| 2024-09-30 08:26 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-09-30 08:25 |
Annual Report
有価証券報告書－第10期(2023/07/01－2024/06/30)
|
Japanese | 1.5 MB | |
| 2024-06-26 08:25 |
Inside Information Statement
臨時報告書
|
Japanese | 18.4 KB | |
| 2024-06-05 09:30 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 86.2 KB | |
| 2024-06-05 09:30 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 171.1 KB | |
| 2024-05-27 08:00 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 101.1 KB | |
| 2024-05-27 08:00 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 250.3 KB | |
| 2024-05-13 08:30 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-05-13 08:30 |
Quarterly Report
四半期報告書－第10期第3四半期(2024/01/01－2024/03/31)
|
Japanese | 156.7 KB | |
| 2024-02-14 07:30 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |